فاس نيوز ميديا جريدة الكترونية جهوية تعنى بشؤون و أخبار جهة فاس مكناس – متجددة على مدار الساعة
Recent data has revealed a significant gap in drug prices between Morocco and other countries, where a medication sold for 580 dirhams in Turkey is priced as high as 5,266 dirhams in Morocco, highlighting major challenges in the country’s pharmaceutical policy.
Need for a Comprehensive Review of Pharmaceutical Policy
The available information points to an urgent need to review the national pharmaceutical policy, especially given the limited purchasing power of many Moroccans. A large number of patients, particularly those with chronic diseases who require long-term treatments, face financial difficulties that threaten their access to essential medicines.
Growing Calls for Reform in the Pharmaceutical Sector
Experts and patients alike have called on the responsible authorities to take urgent measures to address the high prices of medicines by:
- Implementing effective mechanisms to monitor and review drug prices.
- Enhancing transparency in drug pricing and providing accurate information to consumers.
- Supporting and developing the local pharmaceutical industry to reduce dependence on imported medicines.
- Establishing and improving a comprehensive health insurance system to alleviate the financial burden on patients.
Challenges Facing Morocco’s Pharmaceutical System
The pharmaceutical sector faces several obstacles that hinder its growth and impact drug prices, including:
- High costs of importation and customs duties on imported medicines.
- Weak negotiating power of the state with pharmaceutical companies.
- Lack of a clear and coordinated policy regulating generic drugs, which could serve as an economical alternative.
- Limited domestic production of pharmaceutical products compared to increasing local demand.
Summary and Recommendations
The drug price disparity crisis requires swift intervention by the relevant authorities through the development of a comprehensive national strategy to reform the pharmaceutical system, ensuring citizens’ rights to access affordable treatment, promoting transparency and fairness in pricing and distribution, and encouraging the development of local industry and expanded health coverage.
